Thursday, 1 September, 2022 - 16:01
Lixa targets global biotech market
Perth startup Lixa is on the path to commercialising medical research from the University of Western Australia after gaining backing from tech hub CERI and raising $2.2 million.
![]() |
NEWS: Tagged in Lixa assembles AMR avengers | 14 Feb 2025 |
![]() |
NEWS: Tagged in Appointments February 14, 2025 | 13 Feb 2025 |
![]() |
NEWS: Tagged in Lixa move NeoX-101 to clinical trials | 18 Nov 2024 |
![]() |
NEWS: Tagged in Bridging WA's Innovation to Commercialisation Gap | 09 Sep 2024 |
![]() |
NEWS: Tagged in Medtech startup Neurotologix wins WA Innovator of the Year | 05 Dec 2022 |
![]() |
NEWS: Tagged in Lixa targets global biotech market | 01 Sep 2022 |
![]() |
ADDED: Added to Startups list | 25 Aug 2022 |
![]() |
NEW ROLE: Andrew Barker, Chief Scientific Officer | 25 Aug 2022 |
![]() |
NEW ROLE: Craig Ridley, Director, Company Secretary, Chief Financial Officer | 25 Aug 2022 |
![]() |
NEW ROLE: Angela Fonceca, Co-Founder, Chief Operating Officer, Director | 25 Aug 2022 |